AGAPE ATP CORPORATION (ATPC) Current Ratio
- Current ratio · latest quarter: Value 8.45×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 8.45× | Current assets / current liabilities. $24.83M ÷ $2.94M ≈ 8.45× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 24.83M USD | Assets, Current |
| Current obligations | 2.94M USD | Liabilities, Current |
| Cash and equivalents | 45.48K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 21.68K USD | Inventory, Net |
| Payables | (m) | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $24.83M | $2.94M | $45.48K | (m) | (m) | $21.68K | (m) | (m) | 8.45× |
| 2026-03-31 | $24.65M | $2.74M | $220.78K | (m) | $4.37K | $24.79K | (m) | (m) | 9.01× |
| 2025-12-31 | $24.29M | $2.05M | $89.65K | (m) | $4.02K | $26.15K | (m) | (m) | 11.82× |
| 2025-09-30 | $24.07M | $1.49M | $133.71K | (m) | $7.44K | $39.89K | (m) | (m) | 16.21× |
| 2025-06-30 | $24.35M | $1.20M | $215.97K | (m) | $23.92K | $36.30K | (m) | (m) | 20.35× |
| 2025-03-31 | $24.78M | $1.00M | $578.79K | (m) | $41.44K | $36.70K | (m) | (m) | 24.67× |
| 2024-12-31 | $2.78M | $1.12M | $2.04M | (m) | $53.65K | $46.35K | (m) | (m) | 2.48× |
| 2024-09-30 | $3.40M | $946.89K | $2.72M | (m) | $41.94K | $60.56K | (m) | (m) | 3.59× |
| 2024-06-30 | $3.83M | $810.36K | $3.16M | (m) | $41.66K | $53.44K | (m) | (m) | 4.72× |
| 2024-03-31 | $4.27M | $844.29K | $3.58M | (m) | $37.66K | $56.88K | (m) | (m) | 5.06× |
| 2023-12-31 | $5.19M | $1.07M | $4.83M | (m) | $55.46K | $47.91K | (m) | (m) | 4.84× |
| 2023-09-30 | $528.81K | $974.06K | $311.66K | (m) | $22.72K | $56.78K | (m) | (m) | 0.54× |
| 2023-06-30 | $941.44K | $968.33K | $653.75K | (m) | $5.30K | $66.06K | (m) | (m) | 0.97× |
| 2023-03-31 | $1.42M | $1.05M | $1.12M | (m) | $4.02K | $45.42K | (m) | (m) | 1.36× |
| 2022-12-31 | $2.03M | $1.23M | $1.44M | (m) | $2.83K | $46.28K | (m) | (m) | 1.65× |
| 2022-09-30 | $2.36M | $850.00K | $1.58M | (m) | $1.72K | $275.41K | (m) | (m) | 2.77× |
| 2022-06-30 | $2.68M | $924.47K | $1.81M | (m) | $214.00 | $346.74K | (m) | (m) | 2.90× |
| 2022-03-31 | $3.39M | $1.06M | $2.44M | (m) | $3.36K | $379.96K | (m) | (m) | 3.20× |
| 2021-12-31 | $3.91M | $1.31M | $2.60M | (m) | (m) | $375.54K | (m) | (m) | 2.98× |
| 2021-09-30 | $4.17M | $866.24K | $2.88M | (m) | (m) | $475.51K | (m) | (m) | 4.82× |
| 2021-06-30 | $4.61M | $860.38K | $3.30M | (m) | (m) | $490.27K | (m) | (m) | 5.36× |
| 2021-03-31 | $5.12M | $916.98K | $3.35M | (m) | (m) | $543.79K | (m) | (m) | 5.59× |
| 2020-12-31 | $5.68M | $1.04M | $3.52M | (m) | $172.76K | $589.81K | (m) | (m) | 5.47× |
| 2020-09-30 | $5.91M | $986.85K | $3.34M | (m) | $276.80K | $512.78K | (m) | (m) | 5.99× |
| 2020-06-30 | $5.91M | $1.59M | $3.43M | (m) | $325.43K | $416.63K | (m) | (m) | 3.71× |
| 2020-03-31 | $4.08M | $97.46K | $2.59M | (m) | $523.14K | (m) | (m) | (m) | 41.81× |
| 2019-12-31 | $3.54M | $83.99K | $2.74M | (m) | (m) | (m) | (m) | (m) | 42.11× |
| 2019-09-30 | $3.75M | $127.22K | $2.75M | (m) | $628.58K | (m) | (m) | (m) | 29.44× |
| 2019-06-30 | $3.79M | $71.40K | $2.86M | (m) | $433.34K | (m) | (m) | (m) | 53.10× |
| 2019-03-31 | $3.89M | $91.50K | $3.09M | (m) | (m) | (m) | (m) | (m) | 42.52× |
| 2018-12-31 | $3.96M | $241.85K | $3.45M | (m) | (m) | (m) | (m) | (m) | 16.39× |
| 2018-09-30 | $4.22M | $541.03K | $3.84M | (m) | $13.26K | (m) | $47.64K | (m) | 7.81× |
| 2018-06-30 | $3.80M | $29.75K | $3.53M | (m) | (m) | (m) | (m) | (m) | 127.60× |
| 2018-03-31 | $4.17M | $11.61K | $4.11M | (m) | $52.41K | (m) | (m) | (m) | 359.40× |
| 2017-12-31 | $2.71M | $144.29K | $1.86M | (m) | $489.84K | (m) | $131.16K | (m) | 18.77× |
| 2017-09-30 | $2.65M | $398.15K | $2.16M | (m) | $490.47K | (m) | $387.05K | (m) | 6.65× |
| 2017-06-30 | $2.31M | $8.10K | $2.31M | (m) | (m) | (m) | (m) | (m) | 285.52× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |